camptothecin has been researched along with tetraiodothyroacetic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abnous, K; Alibolandi, M; Farzad, SA; Ramezani, M; Rezvani, R; Taghdisi, SM | 1 |
| Abnous, K; Alibolandi, M; Amel Farzad, S; Kalalinia, F; Mohammadi, M; Ramezani, M; Taghdisi, SM | 1 |
2 other study(ies) available for camptothecin and tetraiodothyroacetic acid
| Article | Year |
|---|---|
Tetrac-conjugated polymersomes for integrin-targeted delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Camptothecin; Cell Line, Tumor; Colonic Neoplasms; Drug Delivery Systems; Female; HT29 Cells; Humans; Integrin alphaVbeta3; Mice; Mice, Inbred BALB C; Thyroxine | 2017 |
Tetrac-decorated chitosan-coated PLGA nanoparticles as a new platform for targeted delivery of SN38.
Topics: Animals; Antineoplastic Agents; Biological Transport; Camptothecin; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Liberation; Female; Humans; Integrin alphaVbeta3; Mice; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Thyroxine; Xenograft Model Antitumor Assays | 2018 |